RxSight Inc

RxSight Inc

RXST

Get informed when a big investor buys or sells

+ Follow
Market Cap$258.73M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RxSight IncRxSight Inc-5.5--18%2.10.1
$7.50

Target Price by Analysts

17.6% upsideRxSight Target Price DetailsTarget Price

Share Statistics

Market cap$258.73 Million
Enterprise Value$262.84 Million
Dividend Yield$- (-)
Earnings per Share$-0.95
Beta1.13
Outstanding Shares41,490,889

Return

Return on Equity-17.83%ROE
Return on Assets-13.31%
Return on Invested Capital-18.79%

Valuation & Multiples

P/E Ratio-5.53P/E Ratio
PEG-209.61PEG
Price to Sales2.13Price to Sales
Price to Book Ratio1.06Price to Book Ratio
Enterprise Value to Revenue2.06
Enterprise Value to EBIT-5.14
Enterprise Value to Net Income-6
Total Debt to Enterprise0.07
Debt to Equity0.07Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.21
Average shareholder expectation
Revenue Estimate
$32.07 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 4, 2026
EPS Estimate
$-0.29
Average shareholder expectation
Revenue Estimate
$27.19 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio4.8525 415.05%
Total Calls12,200 41.35%
Total Puts59,200 305.48%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %92.76% 3.77%
Total Invested$235.20M 38.40%
Investors Holding1650%

ESG Score

No data

About RxSight Inc

2,021 employees